HomeREGULATORY
REGULATORY

4th or Later Players Could Also Qualify for PMP If Post-Launch “True Clinical Utility” Premium Granted: MHLW
(Dec.21.2017)

The Ministry of Health, Labor and Welfare (MHLW) intends to make fourth-to-market drugs or later products in a novel class eligible for the so-called price maintenance premium (PMP) if they win the premium for “true clinical utility” following their listing, ministry officials told reporters on December 20 ...
(LOG IN FOR FULL STORY)

News Calendar